Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-13-012429)

Filing Details

Accession Number:: 0001179110-13-012429
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-08-01 16:06:37
Reporting Period:: 2013-07-30

Filing Date:: 2013-08-01
Accepted Time:: 2013-08-01 16:06:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1130598	Onconova Therapeutics Inc.	ONTX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
10456	Baxter International Inc	One Baxter Parkway, Df2-1W Deerfield IL 60015		No	No	Yes	No
1582211	Sa Healthcare Baxter	Thurgauerstrasse 130 Glattpark (Opfikon) V8 8152		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-07-30	2,273,295	$0.00	2,273,295	No	4	C	Direct
Common Stock	Acquisiton	2013-07-30	330,000	$15.00	2,603,295	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series J Convertible Preferred Stock	Disposition	2013-07-30	3,030,303	$0.00	2,273,295	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

The reported securities are owned directly by Baxter Healthcare SA, which is an indirect wholly-owned subsidiary of Baxter International Inc. Baxter International Inc. is an indirect beneficial owner of the reported securities.
The Series J Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.